|
Diabetes, Vol 36, Issue 12 1365-1371, Copyright © 1987 by American Diabetes Association
Insulin secretion and clearance. Comparison after oral and intravenous glucose
ET Shapiro, H Tillil, MA Miller, BH Frank, JA Galloway, AH Rubenstein and KS Polonsky
Department of Medicine, University of Chicago, Pritzker School of Medicine, Illinois 60637.
Insulin secretion and clearance in response to the administration of oral
and intravenous glucose was investigated in nine normal men. C-peptide
metabolic kinetics were calculated by analysis of individual C-peptide
decay curves after the bolus injection of biosynthetic human C-peptide.
Glucose was administered to the subjects on three occasions: as a 75-g oral
dose, a 75-g i.v. infusion, and an intravenous glucose infusion at a
variable rate adjusted to mimic the peripheral glucose levels obtained
after the oral glucose load (matching experiment). Glucose, insulin, and
C-peptide concentrations were measured for the subsequent 5 h. The glucose
level after the oral glucose load (115.9 +/- 2.6 mg/dl, mean +/- SE)
closely approximated that after the matching experiment (120.5 +/- 2.5
mg/dl) but was significantly lower than after 75 g i.v. glucose (127.7 +/-
3.4 mg/dl, P less than .05). Analysis of the areas under the peripheral
concentration curves (60-360 min) showed that the responses of both insulin
(52.7 +/- 5.6 and 46.5 +/- 4.5 pmol.ml-1.300 min-1) and C-peptide (252.7
+/- 27.5 and 267.0 +/- 21.6 pmol.ml-1.300 min-1) were not significantly
different after the oral and 75-g i.v. glucose studies, respectively,
whereas in the matching experiment, both the insulin (26.1 +/- 3.9
pmol.ml-1.300 min-1) and C-peptide (178.0 +/- 18.9 pmol.ml-1.300 min-1)
responses were lower (P less than .05) than in the other two studies.
Insulin secretory rates were derived from peripheral C-peptide
concentrations with an open two-compartment model and individually derived
model parameters. (ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Meier, J. J. Holst, W. E. Schmidt, and M. A. Nauck
Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E849 - E856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Campioni, G. Toffolo, L. T. Shuster, F. J. Service, R. A. Rizza, and C. Cobelli
Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E54 - E60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Nauck, B. Baller, and J. J. Meier
Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes
Diabetes,
December 1, 2004;
53(suppl_3):
S190 - S196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E371 - E385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, E. Breda, A. L. Oberg, C. C. Powell, C. Dalla Man, A. Basu, J. L. Vittone, G. G. Klee, P. Arora, M. D. Jensen, et al.
Mechanisms of the Age-Associated Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, Action, and Clearance
Diabetes,
July 1, 2003;
52(7):
1738 - 1748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Layman, H. Shiue, C. Sather, D. J. Erickson, and J. Baum
Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women during Weight Loss
J. Nutr.,
February 1, 2003;
133(2):
405 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Layman
The Role of Leucine in Weight Loss Diets and Glucose Homeostasis
J. Nutr.,
January 1, 2003;
133(1):
261S - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I. Uwaifo, E. M. Fallon, J. Chin, J. Elberg, S. J. Parikh, and J. A. Yanovski
Indices of Insulin Action, Disposal, and Secretion Derived From Fasting Samples and Clamps in Normal Glucose-Tolerant Black and White Children
Diabetes Care,
November 1, 2002;
25(11):
2081 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I. Uwaifo, S. J. Parikh, M. Keil, J. Elberg, J. Chin, and J. A. Yanovski
Comparison of Insulin Sensitivity, Clearance, and Secretion Estimates Using Euglycemic and Hyperglycemic Clamps in Children
J. Clin. Endocrinol. Metab.,
June 1, 2002;
87(6):
2899 - 2905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brandt, M. Katschinski, R. Arnold, K. S. Polonsky, B. Goke, and M. M. Byrne
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
Am J Physiol Endocrinol Metab,
August 1, 2001;
281(2):
E242 - E247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
Hum. Reprod.,
April 1, 1999;
14(4):
893 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1987 by the American Diabetes Association.
|
|
| |
|